Doctors in Japan can again prescribe an Amgen rare-disease drug to new patients, reversing a recommendation made only days ago following 20 deaths
RSS SUMMARY · AGGREGATED FROM TWSJ
The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
The Japanese drugmaker that sells rare-disease medicine Tavneos said new patients will be able to get the drug, which carries risk of liver injury.
Continue Reading
The full story continues on The Wall Street Journal.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
TWSJ
World News
Opinion | India Is Losing Its Economic Edge
TWSJ·1h ago·3 min read
Business
Months after the Supreme Court struck down President Trump’s most sweeping global tariffs, the administration said it would levy new tariffs using a different legal mechanism
TWSJ·1h ago·3 min read
Business
Terms Revealed for SpaceX’s Unconventional $75 Billion IPO
TWSJ·1h ago·3 min read
Business
Sticker Shock at the Pump Fuels a Surge in Hybrid Sales
TWSJ·1h ago·3 min read
Related
On this beat
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·3h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·6h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·7h ago·3 min read
Health
Diets high in ultraprocessed foods are associated with an increased risk of dementia, a new study says, adding to the list of health problems linked to foods such as cookies, hot dogs and pizza
TWSJ·13h ago·3 min read